Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

November 2020 Issue of The Medicine Maker

In the month’s issue, we examine what lessons from pandemic influenza can be applied to COVID-19 – featuring Russell Basser from Seqirus. We then move far beyond the pandemic to deep space – asking how biologic medicines can be made on-demand for astronauts on long-term space missions. In Profession, Ross T. Burn, CEO at CatSci walks us through the career experiences that have helped shape him, and in NextGen, we find out what can be done to reduce the global incidence of diabetes and its associated conditions. Brexit preparedness, precious metal catalysis, and post-pandemic pharma are all discussed in In My View. And finally, we sit down with Will Downie, CEO of Vectura Group, UK.

Download Issue

Register here to download any issue of The Medicine Maker for FREE.

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Articles featured in this issue

Discovery & Development Vaccines

Beyond the Storm

| Stephanie Sutton

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

Manufacture Advanced Medicine

Informing Consent

| James Strachan

Are seriously ill patients vulnerable to overestimating the benefits and underestimating the risks of gene editing studies?

Manufacture Advanced Medicine

Allogenic Advance

| James Strachan

A step closer to an off-the-shelf CAR T cell therapy.

Manufacture Advanced Medicine

Advanced Medicine in Brief

| James Strachan

A $4-billion acquisition, a key finding for sarcopenia drug development, and algorithmic efficiency… What’s new in advanced medicine?

Discovery & Development Drug Discovery

Poisoning Pain

| Maryam Mahdi

Exploring a new approach to treating IBS pain.

Discovery & Development Clinical Trials

Green Trials

| Stephanie Sutton

Implementing green practices in clinical trials.

Discovery & Development Drug Discovery

Mass Spec Meets Machine learning

| Stephanie Sutton

Can machine learning offer mass spectrometry a boost for drug discovery?

Business & Regulation Business Practice

Brexit Trading Unknowns

| Nik Kotecha

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.

Business & Regulation Business Practice

The Pandemic Diaries

| Erik Haeffler, Don O’Callaghan, Amélie Boulais

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

Manufacture Bioprocessing - Upstream & Downstream

A Grueling Environment

| Phil Williams

NASA ultimately wants to send humans to Mars – and those humans will need medicines.

Manufacture Technology and Equipment

The Astropharmacy Concept

| Stephanie Sutton

How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.

Discovery & Development Drug Delivery

Extraterrestrial Risk

| Stephanie Sutton

What biosecurity risks do exo-microorganisms pose?

Mapping Out MAM

| Sponsored by Thermo Fisher Scientific

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article

Manufacture Vaccines

Preparing for the Next Pandemic

| Stephanie Sutton

A look at the past, present, and future of vaccine production – and how COVID-19 changes the outlook.

Discovery & Development Analytical Science

From Big Pharma to New Green Horizons: Lessons Learned with Ross Burn

| Ross T. Burn

Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.

Manufacture Bioprocessing - Upstream & Downstream

Fighting Viruses with Enhanced ADCC

| Andrew J Racher

Researchers are always looking for new ways to improve effectiveness of antibody therapy.

Discovery & Development Drug Discovery

Diabetes: Finding a Panacea

| Maryam Mahdi

How can we effectively manage the treatment of type 1 diabetes?

Manufacture Contract Manufacturing Services

Getting the Job (Done)

| Stephanie Sutton

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Other issues of 2020